Levocetirizina Fair-Med (Levocetirizine Dihydrochloride)

Levocetirizine selectively blocks peripheral histamine H1 receptors on mast cells, basophils and sensory nerves. By preventing histamine binding, it stops the cascade that causes vasodilation, increased vascular permeability, and nerve activation, thereby diminishing the typical signs of an allergic response.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s age, clinical condition, renal function and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is a second‑generation antihistamine, offering effective symptom control with a lower incidence of sedation compared with first‑generation agents such as cetirizine or diphenhydramine. Compared with other second‑generation drugs like fexofenadine, it may have a slightly faster onset of action, while still maintaining a favorable safety profile.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and direct sunlight. Do not refrigerate or freeze the tablets, and keep them out of reach of children.

Levocetirizina Fair-Med is taken orally, usually as a tablet, with a glass of water. It can be taken with or without food, according to the prescriber’s guidance. Swallow the tablet whole; do not crush or chew unless instructed otherwise.

Serious but rare adverse reactions include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, thrombocytopenia, significant liver enzyme elevations, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, or any signs of an allergic emergency.

Individuals with known hypersensitivity to levocetirizine, its salts, or any excipients in the formulation should avoid the product. Patients with severe renal impairment may require dose adjustment or alternative therapy. Children below the age approved by local regulatory authorities should not be given the medication without specific medical advice.